we were waiting for this novavax due to some concerns with the long term possibilities from the first two mRNA type vaccines.
however, the wait has been very long despite the good novavax trial results
it now appears that the fda will keep going slow on it (and yes I am one that does not like it when they rush approvals too fast, so its a bit of a paradox)
we are somewhat helplessly dependent on these bureaucraps in this, and other matters ... not much as individuals out here we can do
we have made appointment for the existing 2 shot mRNA thing since it is available. praying our concerns prove incorrect
“the company would probably file for approval in the UK first, in about April, before submitting data to the US Food and Drug Administration as soon as May.”
This is later than was expected a month ago. Then they were expecting to request US authorization in April, as was AstraZeneca.
RE: we were waiting for this novavax due to some concerns with the long term possibilities from the first two mRNA type vaccines.
Why are you not considering Johnson & Johnson’s non-mRNA vaccine?